EXPRS2 — ExpreS2ion Biotech Holding AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for ExpreS2ion Biotech Holding AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	SAS	SAS	SAS	SAS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	107	139	111	57.6	81.5
Net Total Accounts Receivable
Net Total Receivables	5.1	7.11	10.8	10.6	12.3
Prepaid Expenses
Total Current Assets	112	146	132	68.7	95
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.29	1.21	0.91	1.77	1.53
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Total Assets	119	152	137	78.7	105
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	18.2	7.46	31.4	11.4	38.2
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	24.3	11.6	34	13.3	40.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	94.5	140	103	65.4	64.4
Total Liabilities & Shareholders' Equity	119	152	137	78.7	105
Total Common Shares Outstanding